These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25735017)

  • 1. Tuberculosis as a force health protection threat to the United States military.
    Sanchez JL; Sanchez JL; Cooper MJ; Hiser MJ; Mancuso JD
    Mil Med; 2015 Mar; 180(3):276-84. PubMed ID: 25735017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis trends in the U.S. Armed Forces, active component, 1998-2012.
    Mancuso JD; Aaron CL
    MSMR; 2013 May; 20(5):4-8. PubMed ID: 23731007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent TB Infection in USSOF: A Refresher and Update.
    Tang SH; Evans JD; Vostal A; Shishido AA
    J Spec Oper Med; 2021; 21(4):108-111. PubMed ID: 34969139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation tuberculosis: role of surveillance.
    DiNardo AR; Guy E
    Expert Rev Anti Infect Ther; 2016; 14(5):501-9. PubMed ID: 27042967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and implementation of a cohort review for latent tuberculosis infection.
    Aaron CL; Mancuso JD
    MSMR; 2014 Dec; 21(12):2-7; discussion 6-7. PubMed ID: 25555208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
    Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
    Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deployment-related testing and treatment for latent tuberculosis infection, part II.
    Mancuso JD; Keep LW
    Mil Med; 2011 Oct; 176(10):1088-92. PubMed ID: 22128639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019.
    Sosa LE; Njie GJ; Lobato MN; Bamrah Morris S; Buchta W; Casey ML; Goswami ND; Gruden M; Hurst BJ; Khan AR; Kuhar DT; Lewinsohn DM; Mathew TA; Mazurek GH; Reves R; Paulos L; Thanassi W; Will L; Belknap R
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(19):439-443. PubMed ID: 31099768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of latent TB infection in areas of high TB prevalence.
    Sharma SK; Mohanan S; Sharma A
    Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
    LoBue PA; Enarson DA; Thoen TC
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Kunst H; Burman M; Arnesen TM; Fiebig L; Hergens MP; Kalkouni O; Klinkenberg E; Orcau À; Soini H; Sotgiu G; Zenner D; de Vries G
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):840-851. PubMed ID: 28786791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].
    Martinez-Lacasa X; Font R; Gonzalez S; Sallent S; Jaen A; Lite J; Cuchi E
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):525-31. PubMed ID: 25613557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis elimination and the challenge of latent tuberculosis.
    Matteelli A; Sulis G; Capone S; D'Ambrosio L; Migliori GB; Getahun H
    Presse Med; 2017 Mar; 46(2 Pt 2):e13-e21. PubMed ID: 28279508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries.
    Padmapriyadarsini C; Sachdeva KS; Nair D; Ramachandran R
    Expert Rev Respir Med; 2021 Jul; 15(7):899-910. PubMed ID: 33302729
    [No Abstract]   [Full Text] [Related]  

  • 18. Is Universal Screening Necessary? Incidence of Tuberculosis among Tibetan Refugees Arriving in Calgary, Alberta.
    Lim R; Jarand J; Field SK; Fisher D
    Can Respir J; 2016; 2016():8249843. PubMed ID: 28127230
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief report: number of tuberculosis tests and diagnoses of latent tuberculosis infection in active component service members, U.S. Armed Forces, January 2004-December 2014.
    Armed Forces Health Surveillance Center (AFHSC)
    MSMR; 2014 Dec; 21(12):8-10; discussion 9-10. PubMed ID: 25555209
    [No Abstract]   [Full Text] [Related]  

  • 20. Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association.
    Cole B; Nilsen DM; Will L; Etkind SC; Burgos M; Chorba T
    MMWR Recomm Rep; 2020 Jul; 69(7):1-27. PubMed ID: 32730235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.